Rezolute, Inc. (RZLT): Total Assets
$112.85M
As of 2026-06-30
-3.0%
3-year compound annual growth
+21.5%
5-year compound annual growth
+26.3%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $112.85M | -35.7% | 2026-09-24, Balance as of period end |
| 2025-06-30 | $175.49M | +32.2% | 2026-09-24, Balance as of period end |
| 2024-06-30 | $132.74M | +7.3% | 2025-09-17, Balance as of period end |
| 2023-06-30 | $123.72M | -18.8% | 2024-09-19, Balance as of period end |
| 2022-06-30 | $152.42M | +257.7% | 2023-09-14, Balance as of period end |
| 2021-06-30 | $42.61M | +288.6% | 2022-09-15, Balance as of period end |
| 2020-06-30 | $10.96M | -10.5% | 2021-09-15, Balance as of period end |
| 2019-06-30 | $12.25M | +389.5% | 2020-10-13, Balance as of period end |
| 2018-06-30 | $2.50M | -76.5% | 2019-09-10, Balance as of period end |
| 2017-06-30 | $10.63M | -2.5% | 2018-10-15, Balance as of period end |
| 2016-06-30 | $10.90M | -3.2% | 2017-09-22, Balance as of period end |
| 2015-06-30 | $11.26M | +52.1% | 2016-09-28, Balance as of period end |
| 2014-06-30 | $7.40M | +570.7% | 2015-09-28, Balance as of period end |
| 2013-06-30 | $1.10M | +3.3% | 2014-09-30, Balance as of period end |
| 2012-06-30 | $1.07M | n/a | 2013-09-11, Balance as of period end |
| 2011-12-31 | $565.8K | n/a | 2013-09-11, Balance as of period end |
| 2011-06-30 | $37.0K | n/a | 2012-11-09, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Rezolute, Inc. (RZLT) | 2026-06-30 | $112.85M | -35.7% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $113.51M | -49.8% |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $113.56M | +50.4% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $114.11M | +17.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $116.48M | -27.3% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $116.56M | -39.1% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $117.18M | +51.2% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $108.42M | -34.1% |
Compare RZLT, KRRO, MIST, RFL side by side · Screen every company in Pharmaceutical Preparations ↗